BCPC Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Sustained Margin And Earnings ExpansionConsistent EBITDA growth alongside a 36.5% gross margin shows durable operating discipline and pricing or mix benefits. Continued margin expansion can support earnings growth even when volume growth is uneven.
Conservative Balance Sheet And Strong Cash GenerationRobust cash generation and sharply reduced leverage improve financial resilience, funding capacity, and strategic flexibility. Cash flow materially above net income also supports the quality and durability of reported earnings.
Diversified Growth Across Specialty Nutrition MarketsGrowth across all three segments reduces dependence on any single end market and demonstrates broad customer demand. Specialty formulations, delivery systems, and regulated applications can reinforce customer relationships and support repeat business.
Bears Say
Modest Underlying Revenue GrowthA slow and uneven top line limits operating leverage and makes future earnings more dependent on efficiency, mix, and pricing. Sustained volume expansion is not yet established across the broader business.
Exposure To Elevated Manufacturing Input CostsBalchem remains exposed to raw-material and manufacturing cost inflation, which can compress margins when customer price increases lag costs. Ongoing mitigation may protect profitability but can require additional operating effort and investment.
Pricing And Floating-rate Exposure Constrain Growth QualityPrice-led growth may prove less durable than volume-led expansion, while floating-rate debt leaves funding costs sensitive to interest rates. Together, these factors can moderate demand quality and future margin or cash-flow conversion.
Balchem News
BCPC FAQ
What was Balchem Corp.’s price range in the past 12 months?
Currently, no data Available
What is Balchem Corp.’s market cap?
Balchem Corp.’s market cap is $91.21B.
When is Balchem Corp.’s upcoming earnings report date?
Balchem Corp.’s upcoming earnings report date is Oct 23, 2026 which is in 42 days.
How were Balchem Corp.’s earnings last quarter?
Balchem Corp. released its earnings results on Jul 31, 2026. The company reported $24.059 earnings per share for the quarter, beating the consensus estimate of $22.069 by $1.991.
Is Balchem Corp. overvalued?
According to Wall Street analysts Balchem Corp.’s price is currently Undervalued.
Does Balchem Corp. pay dividends?
Balchem Corp. does not currently pay dividends.
What is Balchem Corp.’s EPS estimate?
Balchem Corp.’s EPS estimate is 24.75.
How many shares outstanding does Balchem Corp. have?
Currently, no data Available
What happened to Balchem Corp.’s price movement after its last earnings report?
Balchem Corp. reported an EPS of $24.059 in its last earnings report, beating expectations of $22.069. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Balchem Corp.?
Currently, no hedge funds are holding shares in MX:BCPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Balchem Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3,630.78 (― Upside)
$3,630.78 (― Upside)
Blogger Sentiment
Bullish
MX:BCPC Sentiment 100%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.87%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.52%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Balchem Corp.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
BCPC Company Deck
BCPC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a strongly positive operational and financial performance: record revenues, profits, adjusted EBITDA, broad-based segment growth, solid cash flow, low leverage, and strategic balance sheet actions (refinancing and buybacks). Headwinds noted include elevated input costs, slightly higher operating expenses and taxes, floating-rate exposure, and some reliance on pricing in A&H. On balance the positives — consistent record results, sustained growth momentum (28 consecutive quarters of adjusted EBITDA growth), and improved financial flexibility — materially outweigh the limited headwinds.View all MX:BCPC earnings summariesBCPC Stock 12 Month Forecast
Average Price Target
―Ashland
―
Innospec
―
International Flavors & Fragrances
―
Sensient Technologies
―
Stepan Company
―